Full Length Research Paper
Depression in Oncological Patients-A Study
Sophio brunjadze1*
; Shorena Vashadze2
and Ketevan Dolidze3
1
-Ph.D Student, Shota Rustaveli State University Batumi, Georgia.
2-
Assistant Professor, Shota Rustaveli State University Batumi, Georgia.
3-
Ph.D.in Biological Science, Professor, Batumi Shota Rustaveli State University, Georgia.
ABSTRACT
The aim of the study is to analyze the clinical features of depressive disorders in oncological patients,
initial severity, age, sex of the patient and duration of the disease. Medical research was conducted
on 100 oncological patients aged from 25 to 70 years, men were 45, and 55 women. A group of
patients were separated with breast cancer (28% of all cases), prostate cancer (21%), malignant
tumors of the cervix (26%), skin cancer (28%). Depressive disorders were detected in 95 people (55
women and 40 men). The average age was 56.4 years. Patients with malignant cervical tumors with
mild depressive episode (M/DE) were observed in 14, with a moderate depressive episode (MDE),
there were 9 people and severe (TDE) – were 2, breast cancer (MDE) was observed in 17 people . Six
people were observed with MDE, with severe (SDE) -2. Depressive disorders were detected in 20
patients (prostate cancer). The mild depressive episode (MDE) was observed in 15 patients. MDE was
observed in 4 people with severe (SDE) y-1. Depressive disorders were detected in 80% of patients
with skin cancer. A mild depressive episode was observed in 12 people, a severe depressive episode
was observed at-3. Among them were 20 men and 3 women. the acute period (after the diagnosis of
the disease), there were examined 35 cancer patients, after 2-4 months 26 patients; after 5-11
months 35 patients; 12 months after the stroke- 4 patients. In an acute period a mild depressive
episode was observed in 5 patients, with a moderate depressive episode were observed 13 people
and a severe depressive episode was observed in 2 people. After 2-4 months a mild depressive
episode was observed in 20 patients, with a moderate depressive episode were observed 3 people, a
severe depressive episode was observed in 11 patients, 6 of them were women. After 5-11 months – A
mild depressive episode was observed in 21 patients. A moderate depressive episode was observed in
7 people, Severe depressive episode was observed in 3. After 12 months – A mild depressive episode
was observed in 3 patients, a mild depressive episode was observed in 2 people, a severe depressive
episode was observed in 1 woman. The tendency to develop the depression after 6 months of the
disease is noted by most researchers. 1.2. Depression (up to 72.2%) was detected in patients at the
late period. after 2-4-11 months. Depression diagnosis is high in cervical cancer and in patients with
skin cancer. The presence of depressive symptoms is associated with decreased survival at the cancer
period, probable that an important factor is the deterioration of patients’ self-care. Psychotherapy
increases patient adherence to treatment, encourages them to take care of themselves, increases the
resistance of the body. The different aspects of mental and psychological disorders in oncological
diseases are more effectively treated by different therapies, for example, the fear of relapse is better
amenable to treatment in CTA, whereas the coping with loss and transition of roles are more
susceptible to MAT.